FAT1 is one of the most frequently mutated TSGs in cancer whose LOF enhances tumor invasiveness, metastasis, and drug resistance (33, 34), suggesting a link between APOBEC-induced protein truncations and disease outcomes. This evidence concerns the gene FAT1 and neoplasm.